MEI Pharma (MEIP) Needs To Raise Capital; PT Lowered to $2 - Wedbush
Tweet Send to a Friend
Wedbush analyst, David Nierengarten, cut his PT on MEI Pharma (NASDAQ: MEIP) to $2 from $3 even though the Ph ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
